readthroughSign in
CompanyTRAXNasdaqSan Diego, CA

First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics develops antibody therapies targeting immune pathways in autoimmune and inflammatory diseases.

10-QNov 12Latest SEC filing
Nov 3Latest story